Press Releases

The official home of Magnus Medical press releases. View our latest announcements and corporate updates regarding the path toward more effective depression care.

Press Releases
Magnus Medical Announces Uninterrupted 2026 Payment Stability for SAINT Neuromodulation in CMS OPPS Final Rule
Final Rule maintains SAINT® Depression Therapy reimbursement framework, ensuring payment continuity for hospitals and hospital-based outpatient providers
Press Releases
Magnus Medical Announces CMS Approval of New Payment Rate for SAINT Treatment in 2025 Hospital Outpatient Rule
New rule significantly expands access to SAINT therapy for treatment-resistant major depression
Press Releases
Magnus Medical Announces First Patient Enrolled at University of Massachusetts in Pivotal DoD-Funded Multisite Study of SAINT for Postpartum Depression

BURLINGAME, Calif., Feb. 5, 2026 — Magnus Medical, Inc., a pioneering therapeutic neuromodulation company advancing…

Press Releases
Magnus Medical Announces Uninterrupted 2026 Payment Stability for SAINT Neuromodulation in CMS OPPS Final Rule

Final Rule maintains SAINT® Depression Therapy reimbursement framework, ensuring payment continuity for hospitals and hospital-based…

Press Releases
Magnus Medical Announces CMS Approval of New Payment Rate for SAINT Treatment in 2025 Hospital Outpatient Rule
Press Releases
Magnus Medical Highlights New Clinical Data on Groundbreaking SAINT Therapy at 2024 NYC Neuromodulation Conference
Press Releases
Magnus Medical Announces Commercial Launch of Groundbreaking SAINT Neuromodulation System
Press Releases
Magnus Medical Announces American Medical Association Issues New CPT Category III Codes for Targeted, Accelerated Intermittent Theta-Burst Stimulation
Press Releases
Magnus Medical Announces First Participants Treated in Study Using SAINT Neuromodulation System for Major Depression
Press Releases
Magnus Medical Shares New Study Results That Find Treatment With SAINT for Severe Depression Changes Abnormal Brain Signals
Press Releases
Magnus Medical Receives FDA Clearance for the SAINT Neuromodulation System for Non-Invasive, Individualized and Precise Treatment of Severe Depression
Press Releases
Magnus Adds Three Key Hires to Executive Team
Press Releases
Magnus Medical Launches with Breakthrough Device Designation for Rapid, Individualized Treatment of Major Depression and $25M in Series A Financing

Find SAINT® near you

The path to feeling better is here. Find a Verified SAINT Provider near you.

Find a provider